RDN | Ticker Profile - Titan Protect

RDN

Radian Group Inc.

Financial Services · Insurance - Specialty · NYQ

$33.80

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$4.7B

Total market value of the company

Trailing P/E

8.23

Very cheap relative to earnings

Forward P/E

6.43

Based on estimated future earnings — lower means cheaper

Rev Growth

+58.8%

Year-over-year revenue change

Profit Margin

41.0%

How much profit the company keeps from each dollar of revenue

ROE

12.7%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$44.00

+30% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 6 analysts covering this stock

About Radian Group Inc.

Radian Group Inc., together with its subsidiaries, provides mortgage insurance in the United States. It aggregates, manages, and distributes mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors through private mortgage insurance on residential first-lien mortgage loans. The company also offers private mortgage insurance, specialty insurance, and reinsurance lines. It serves mortgage originators, such as mortgage banks, commercial banks, savings institutions, credit unions, and community banks. The company was formerly known as CMAC Investment Corp. and changed its name to Radian Group Inc. in June 1999. Radian Group Inc. was founded in 1977 and is headquartered in Wayne, Pennsylvania.

https://www.radian.com

Country: United States Employees: 900 Industry: Insurance - Specialty

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

FAIL

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.512

Good returns relative to risk taken

Kelly Fraction

0.0340

Modest edge detected — smaller position warranted

Calmar Ratio

0.621

Acceptable balance between returns and drawdown risk

Annual Return

10.2%

Historical annualised return based on price data

Max Drawdown

-16.5%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.76

Less volatile than the market — more defensive

52W High

$38.84

13% below the year high

52W Low

$31.50

7% above the year low

Avg Volume

1,340,960

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.7

Days it would take all short sellers to cover — higher means more crowded

Short % Float

3.9%

Low short interest — limited bearish positioning

Div Yield

289.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$4.29

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

28.68

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.57

Healthy liquidity position

Quick Ratio

0.62

Like current ratio but excludes inventory — stricter test

Gross Margin

82.5%

Revenue left after cost of goods — higher means pricing power

Operating Margin

46.6%

Profit from core operations before interest and tax

Free Cash Flow

$276M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.4B

Total revenue over the last 12 months

Net Income

$596M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$48.00

Target Median

$44.00

Target Low

$37.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go